MedPath

Talima Therapeutics, Inc.

Talima Therapeutics, Inc. logo
🇺🇸United States
Ownership
Private
Established
2004-01-01
Employees
1
Market Cap
-
Website
http://www.talima.com

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

A Study to Evaluate TMI-358 in the Treatment of Distal Subungual Onychomycosis

Phase 2
Terminated
Conditions
Distal Subungual Onychomycosis
Interventions
Drug: MMI-467
First Posted Date
2010-03-25
Last Posted Date
2011-01-17
Lead Sponsor
Talima Therapeutics, Inc.
Target Recruit Count
120
Registration Number
NCT01093118
Locations
🇺🇸

Radiant Research, Inc., Cincinnati, Ohio, United States

🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

🇺🇸

International Dermatology Research Center, Miami, Florida, United States

and more 3 locations

News

No news found
© Copyright 2025. All Rights Reserved by MedPath